These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 20054688)

  • 41. [Enhanced antitumor effects induced by lymphotactin gene-modified dendritic cells after pulsed with tumor antigen peptide].
    Zhang W; He L; Cao X
    Zhonghua Yi Xue Za Zhi; 1999 Mar; 79(3):170-3. PubMed ID: 11601032
    [TBL] [Abstract][Full Text] [Related]  

  • 42. TNF-alpha-treated DC exacerbates disease in a murine tumor metastasis model.
    Vohra N; Verhaegen M; Martin L; Mackay A; Pilon-Thomas S
    Cancer Immunol Immunother; 2010 May; 59(5):729-36. PubMed ID: 19921187
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Potent in vivo anti-tumor activity of isolated CD62L(low) lymph node cells sensitized in vivo with tumor lysate-pulsed DC-based vaccines.
    Liu Z; Fan H; Wu Y; Chen B
    Cytotherapy; 2005; 7(4):353-62. PubMed ID: 16162457
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Enhanced antitumor immunity by targeting dendritic cells with tumor cell lysate-loaded chitosan nanoparticles vaccine.
    Shi GN; Zhang CN; Xu R; Niu JF; Song HJ; Zhang XY; Wang WW; Wang YM; Li C; Wei XQ; Kong DL
    Biomaterials; 2017 Jan; 113():191-202. PubMed ID: 27816821
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Improvement of dendritic-based vaccine efficacy against hepatitis B virus-related hepatocellular carcinoma by two tumor-associated antigen gene-infected dendritic cells.
    Yang JY; Cao DY; Xue Y; Yu ZC; Liu WC
    Hum Immunol; 2010 Mar; 71(3):255-62. PubMed ID: 20036295
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Inhibiting effect of IL-10 in tumor microenvironment on anti-tumor activity of SOCS1-silenced DC vaccine].
    Wang Z; You H; Song S
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Apr; 29(4):379-83. PubMed ID: 23643168
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Enhancing Dendritic Cell-based Immunotherapy with IL-2/Monoclonal Antibody Complexes for Control of Established Tumors.
    Kim MT; Richer MJ; Gross BP; Norian LA; Badovinac VP; Harty JT
    J Immunol; 2015 Nov; 195(9):4537-44. PubMed ID: 26408669
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Anti-tumor effect of cisplatin combined with DC vaccine on tumor-bearing mice].
    You HY; Lian WG; Zhang HL; Wang JX; Zhang KX; Song SX
    Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):336-40. PubMed ID: 22883452
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interferon-α Up-Regulates the Expression of PD-L1 Molecules on Immune Cells Through STAT3 and p38 Signaling.
    Bazhin AV; von Ahn K; Fritz J; Werner J; Karakhanova S
    Front Immunol; 2018; 9():2129. PubMed ID: 30356906
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines.
    Zitvogel L; Mayordomo JI; Tjandrawan T; DeLeo AB; Clarke MR; Lotze MT; Storkus WJ
    J Exp Med; 1996 Jan; 183(1):87-97. PubMed ID: 8551248
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ascophyllan functions as an adjuvant to promote anti-cancer effect by dendritic cell activation.
    Zhang W; Okimura T; Xu L; Zhang L; Oda T; Kwak M; Yu Q; Jin JO
    Oncotarget; 2016 Apr; 7(15):19284-98. PubMed ID: 27008707
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Polysaccharide purified from Ganoderma lucidum induced activation and maturation of human monocyte-derived dendritic cells by the NF-kappaB and p38 mitogen-activated protein kinase pathways.
    Lin YL; Liang YC; Lee SS; Chiang BL
    J Leukoc Biol; 2005 Aug; 78(2):533-43. PubMed ID: 15894585
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tumor cell lysate-pulsed dendritic cells are more effective than TCR Id protein vaccines for active immunotherapy of T cell lymphoma.
    Gatza E; Okada CY
    J Immunol; 2002 Nov; 169(9):5227-35. PubMed ID: 12391241
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Increased numbers of monocyte-derived dendritic cells during successful tumor immunotherapy with immune-activating agents.
    Kuhn S; Hyde EJ; Yang J; Rich FJ; Harper JL; Kirman JR; Ronchese F
    J Immunol; 2013 Aug; 191(4):1984-92. PubMed ID: 23858033
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Improved tumor immunity using anti-tyrosinase related protein-1 monoclonal antibody combined with DNA vaccines in murine melanoma.
    Saenger YM; Li Y; Chiou KC; Chan B; Rizzuto G; Terzulli SL; Merghoub T; Houghton AN; Wolchok JD
    Cancer Res; 2008 Dec; 68(23):9884-91. PubMed ID: 19047169
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fusion of Bacterial Flagellin to a Dendritic Cell-Targeting αCD40 Antibody Construct Coupled With Viral or Leukemia-Specific Antigens Enhances Dendritic Cell Maturation and Activates Peptide-Responsive T Cells.
    Schmitt S; Tahk S; Lohner A; Hänel G; Maiser A; Hauke M; Patel L; Rothe M; Josenhans C; Leonhardt H; Griffioen M; Deiser K; Fenn NC; Hopfner KP; Subklewe M
    Front Immunol; 2020; 11():602802. PubMed ID: 33281829
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cancer Stem Cell Vaccination With PD-L1 and CTLA-4 Blockades Enhances the Eradication of Melanoma Stem Cells in a Mouse Tumor Model.
    Zheng F; Dang J; Zhang H; Xu F; Ba D; Zhang B; Cheng F; Chang AE; Wicha MS; Li Q
    J Immunother; 2018 Oct; 41(8):361-368. PubMed ID: 30063587
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fluorine-19 Cellular MRI Detection of In Vivo Dendritic Cell Migration and Subsequent Induction of Tumor Antigen-Specific Immunotherapeutic Response.
    Fink C; Smith M; Gaudet JM; Makela A; Foster PJ; Dekaban GA
    Mol Imaging Biol; 2020 Jun; 22(3):549-561. PubMed ID: 31286351
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dendritic cells, pulsed with lysate of allogeneic tumor cells, are capable of stimulating MHC-restricted antigen-specific antitumor T cells.
    Mahdian R; Kokhaei P; Najar HM; Derkow K; Choudhury A; Mellstedt H
    Med Oncol; 2006; 23(2):273-82. PubMed ID: 16720928
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mechanisms involved in radiation enhancement of intratumoral dendritic cell therapy.
    Teitz-Tennenbaum S; Li Q; Okuyama R; Davis MA; Sun R; Whitfield J; Knibbs RN; Stoolman LM; Chang AE
    J Immunother; 2008 May; 31(4):345-58. PubMed ID: 18391761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.